José Rocha

791 total citations
48 papers, 644 citations indexed

About

José Rocha is a scholar working on Psychiatry and Mental health, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, José Rocha has authored 48 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Neurology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in José Rocha's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Epilepsy research and treatment (13 papers) and Neurological disorders and treatments (10 papers). José Rocha is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Epilepsy research and treatment (13 papers) and Neurological disorders and treatments (10 papers). José Rocha collaborates with scholars based in Portugal, Brazil and Germany. José Rocha's co-authors include Patrício Soares‐da‐Silva, Teresa Nunes, Luís Almeida, Amílcar Falcão, Lyndon Wright, Roberto Magalhães Pinto, Ana I. Loureiro, Maria João Bonifácio, Manuel Vaz‐da‐Silva and P. Nuno Palma and has published in prestigious journals such as Epilepsia, Clinical Pharmacokinetics and Journal of the Neurological Sciences.

In The Last Decade

José Rocha

45 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Rocha Portugal 14 332 236 183 158 59 48 644
Desheng Zhai China 13 65 0.2× 53 0.2× 45 0.2× 29 0.2× 43 0.7× 38 444
Hatice Aygün Türkiye 12 76 0.2× 51 0.2× 24 0.1× 86 0.5× 54 0.9× 44 387
M. J. Hamilton United Kingdom 12 331 1.0× 281 1.2× 19 0.1× 124 0.8× 17 0.3× 16 545
C. Gomeni France 9 204 0.6× 126 0.5× 13 0.1× 60 0.4× 26 0.4× 12 467
Riitta Tokola Finland 9 138 0.4× 56 0.2× 72 0.4× 82 0.5× 6 0.1× 12 358
Abadi Kahsu Gebre Ethiopia 13 49 0.1× 57 0.2× 20 0.1× 68 0.4× 79 1.3× 30 524
Janko Samardžić Serbia 13 39 0.1× 95 0.4× 22 0.1× 72 0.5× 20 0.3× 63 522
Patricia Risède France 16 66 0.2× 100 0.4× 23 0.1× 165 1.0× 17 0.3× 35 633
Esra Gürkaş Türkiye 11 63 0.2× 51 0.2× 74 0.4× 45 0.3× 7 0.1× 39 312
E S Johnson United Kingdom 17 60 0.2× 36 0.2× 97 0.5× 206 1.3× 109 1.8× 36 774

Countries citing papers authored by José Rocha

Since Specialization
Citations

This map shows the geographic impact of José Rocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Rocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Rocha more than expected).

Fields of papers citing papers by José Rocha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Rocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Rocha. The network helps show where José Rocha may publish in the future.

Co-authorship network of co-authors of José Rocha

This figure shows the co-authorship network connecting the top 25 collaborators of José Rocha. A scholar is included among the top collaborators of José Rocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Rocha. José Rocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, Joaquim J., Miguel Gago, Raquel Costa, et al.. (2024). Opicapone Effect on Sleep Disorders in Fluctuating Parkinson’s Disease Patients: Findings from the OASIS Trial. Parkinsonism & Related Disorders. 122. 106130–106130.
2.
3.
Ebersbach, Georg, Joaquim J. Ferreira, Angelo Antonini, et al.. (2020). Opicapone's added benefit as a first-line adjunctive therapy to levodopa and when used promptly for motor fluctuations in Parkinson's disease. Parkinsonism & Related Disorders. 79. e71–e72. 1 indexed citations
4.
Biton, Victor, Joanne Rogin, Gregory L. Krauss, et al.. (2017). Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials. Epilepsy & Behavior. 72. 127–134. 42 indexed citations
5.
Rocha, José, et al.. (2017). Lipidograma, função hepática e produção de leite em vacas suplementadas com somatotropina recombinante bovina. Veterinária e Zootecnia. 24(2). 316–322.
6.
Rocha, José, et al.. (2015). Prevalência sorológica de Leptospira spp. em bovinos leiteiros na microrregião de Francisco Beltrão. Veterinária e Zootecnia. 22(3). 392–395. 1 indexed citations
7.
Baldissera, Matheus D., Nathieli B. Bottari, Alexandre A. Tonin, et al.. (2015). Effect of zinc supplementation on ecto-adenosine deaminase activity in lambs infected by Haemonchus contortus: Highlights on acute phase of disease. Experimental Parasitology. 151-152. 34–38. 6 indexed citations
8.
Rocha, José, et al.. (2015). Oxidative stress by Haemonchus contortus in lambs: Influence of treatment with zinc edetate. Research in Veterinary Science. 102. 22–24. 10 indexed citations
9.
Almeida, Luís, Teresa Nunes, Raquel Costa, et al.. (2013). Etamicastat, a Novel Dopamine β-Hydroxylase Inhibitor: Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Hypertension. Clinical Therapeutics. 35(12). 1983–1996. 27 indexed citations
10.
Rocha, José, A. Santos, Amílcar Falcão, et al.. (2013). Effect of moderate liver impairment on the pharmacokinetics of opicapone. European Journal of Clinical Pharmacology. 70(3). 279–286. 23 indexed citations
11.
Nunes, Teresa, José Rocha, Amílcar Falcão, Luís Almeida, & Patrício Soares‐da‐Silva. (2012). Steady‐state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers. Epilepsia. 54(1). 108–116. 66 indexed citations
12.
Almeida, Luís, José Rocha, Amílcar Falcão, et al.. (2012). Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects. Clinical Pharmacokinetics. 52(2). 139–151. 69 indexed citations
13.
Vaz‐da‐Silva, Manuel, Teresa Nunes, José Rocha, et al.. (2011). Effect of Food on the Pharmacokinetic Profile of Etamicastat (BIA 5-453). Drugs in R&D. 11(2). 127–136. 5 indexed citations
14.
Rocha, José, Manuel Vaz‐da‐Silva, Teresa Nunes, et al.. (2011). Single‐Dose Tolerability, Pharmacokinetics, and Pharmacodynamics of Etamicastat (BIA 5–453), a New Dopamine β‐Hydroxylase Inhibitor, in Healthy Subjects. The Journal of Clinical Pharmacology. 52(2). 156–170. 20 indexed citations
15.
Nunes, Teresa, José Rocha, Manuel Vaz‐da‐Silva, et al.. (2011). Pharmacokinetics and Tolerability of Etamicastat Following Single and Repeated Administration in Elderly Versus Young Healthy Male Subjects: An Open-Label, Single-Center, Parallel-Group Study. Clinical Therapeutics. 33(6). 776–791. 12 indexed citations
16.
Nunes, Teresa, José Rocha, Manuel Vaz‐da‐Silva, et al.. (2010). Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects. Drugs in R&D. 10(4). 225–242. 21 indexed citations
17.
18.
Milovan, Denise, Luís Almeida, Myroslava K. Romach, et al.. (2010). Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. Epilepsy & Behavior. 18(4). 366–373. 35 indexed citations
19.
Almeida, Luís, Teresa Nunes, Étienne Sicard, et al.. (2009). Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects. Acta Neurologica Scandinavica. 121(4). 257–264. 30 indexed citations
20.
Vaz‐da‐Silva, Manuel, Ana I. Loureiro, Teresa Nunes, et al.. (2008). Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg. Drugs in R&D. 9(6). 435–446. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Desheng Zhai Breakdown of academic impact, for papers by Hatice Aygün Breakdown of academic impact, for papers by M. J. Hamilton Breakdown of academic impact, for papers by C. Gomeni Breakdown of academic impact, for papers by Riitta Tokola Breakdown of academic impact, for papers by Abadi Kahsu Gebre Breakdown of academic impact, for papers by Janko Samardžić Breakdown of academic impact, for papers by Patricia Risède Breakdown of academic impact, for papers by Esra Gürkaş Breakdown of academic impact, for papers by E S Johnson
Rankless by CCL
2026